Golden State Today

California Attorney General Rob Bonta released a statement following the U.S. Supreme Court's decision to overturn the U.S. Court of Appeals for the Fifth Circuit’s ruling on access to mifepristone, a drug used for medication abortion and miscarriage treatment.

“Today’s ruling overturns the Fifth Circuit’s decision to impose medically unnecessary and harmful restrictions on access to mifepristone,” said Attorney General Bonta. “Yet, the fight for reproductive rights across the country is far from over, as anti-abortion extremists stand ready to continue their meritless attacks on mifepristone and access to reproductive healthcare. No matter how many lawsuits they file or challenges they bring, they cannot change the facts: mifepristone is safe and effective—so safe, in fact, that it carries a lower risk of serious complications than taking Tylenol or undergoing a colonoscopy. At the California Department of Justice, we remain unwavering in our commitment to ensure that our state continues to be a safe haven for all individuals seeking reproductive healthcare services and medication.”

Attorney General Bonta emphasized his commitment to supporting, expanding, and protecting reproductive freedom. In January 2024, he joined a coalition of 24 state attorneys general in filing an amicus brief in the U.S. Supreme Court supporting federal regulations that preserve full access to mifepristone. Additionally, in March 2024, he issued a statement responding to the Supreme Court’s oral arguments in this case.